(Q47248668)

English

Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

Adaptive radiation therapy

0 references

quality of life

1 reference

based on heuristic

inferred from title

object named as

Irene M Lips

1

0 references

author name string

Carla H van Gils

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

Uulke A van der Heide

3

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

Arto E Boeken Kruger

4

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

Marco van Vulpen

5

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

publication date

16 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

103

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

762-767

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

What dose of external-beam radiation is high enough for prostate cancer?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.08117.X

21 January 2018

Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.08117.X

21 January 2018

Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.08117.X

21 January 2018

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.08117.X

21 January 2018

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.08117.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2008.08117.X

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/18990145

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47248668&oldid=2147938579"